US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ultragenyx Pharmaceutical

34.60

-0.5700-1.62%

Post-market: 35.500.9000+2.60%19:32 EDT

Volume:1.27M

Turnover:44.07M

Market Cap:3.33B

PE:-6.27

High:35.38

Open:34.99

Low:34.36

Close:35.17

52wk High:53.47

52wk Low:25.81

Shares:96.37M

Float Shares:92.79M

Volume Ratio:0.99

T/O Rate:1.37%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.5219

EPS(LYR):-6.2867

ROE:-180.44%

ROA:-21.59%

PB:22.04

PE(LYR):-5.50

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL)

Ultragenyx announces first patient dosed in Aurora study

Ultragenyx Doses First Patient in Aurora Trial for Angelman Syndrome

Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating Gtx-102 in Additional Angelman Syndrome Genotypes and Age Groups

THOMSON REUTERS

Ultragenyx Pharmaceutical Inc. to Release Third Quarter 2025 Financial Results

Ultragenyx Grants Restricted Stock Units to New Hires Under Inducement Plan

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS

Press Release: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx price target lowered to $74 from $79 at BofA

BofA Securities Adjusts Ultragenyx Pharmaceutical Price Target to $74 From $79, Maintains Buy Rating

MT Newswires Live

Ultragenyx Pharmaceutical Inc : Bofa Global Research Cuts Price Objective to $74 From $79

THOMSON REUTERS

Wedbush Lifts Price Target on Ultragenyx Pharmaceutical to $35 From $34, Keeps Neutral Rating

MT Newswires Live

Ultragenyx Grants Stock Options and RSUs to New Hire Under Inducement Plan Approved by Board

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx placed on ‘Positive Catalyst Watch’ at JPMorgan

Press Release: Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President

Cantor Fitzgerald Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Karah Parschauer, EVP and Chief Legal Officer, Reports Disposal of Common Shares of Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical: Promising Phase 3 Results for DTX401 Reinforce Buy Rating

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RARE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RARE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","market":"US","secType":"STK","nameCN":"Ultragenyx Pharmaceutical","latestPrice":34.6,"timestamp":1761940800000,"preClose":35.17,"halted":0,"volume":1267731,"hourTrading":{"tag":"盘后","latestPrice":35.5,"preClose":34.6,"latestTime":"19:32 EDT","volume":30793,"amount":1065564.64,"timestamp":1761953579993},"delay":0,"floatShares":92794919,"shares":96371643,"eps":-5.521909,"marketStatus":"Market Closed","change":-0.57,"latestTime":"10-31 16:00:00 EDT","open":34.99,"high":35.38,"low":34.355,"amount":44067128.23053,"amplitude":0.029144,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.521909,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1391144400000,"exchange":"NASDAQ","adjPreClose":35.17,"preHourTrading":{"tag":"盘前","latestPrice":35.17,"preClose":35.17,"latestTime":"09:18 EDT","volume":1027,"amount":36132.55074,"timestamp":1761916714333},"postHourTrading":{"tag":"盘后","latestPrice":35.5,"preClose":34.6,"latestTime":"19:32 EDT","volume":30793,"amount":1065564.64,"timestamp":1761953579993},"volumeRatio":0.9919126317076389,"impliedVol":0.7269,"impliedVolPercentile":0.816},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RARE\",,,,,undefined,":{"symbol":"RARE","floatShares":92794919,"roa":"-21.59%","roe":"-180.44%","lyrEps":-6.286667,"volumeRatio":0.9919126317076389,"shares":96371643,"dividePrice":0,"high":35.38,"amplitude":0.029144,"preClose":35.17,"low":34.355,"week52Low":25.81,"pbRate":"22.04","psRate":"5.46","week52High":53.47,"institutionHeld":0,"latestPrice":34.6,"eps":-5.521909,"divideRate":0,"volume":1267731,"delay":0,"ttmEps":-5.521909,"open":34.99,"prevYearClose":42.07,"prevWeekClose":33.53,"prevMonthClose":34.6,"prevQuarterClose":30.08,"fiveDayClose":33.53,"twentyDayClose":31.21,"sixtyDayClose":27.83,"earningDate":1762185600000,"earningTime":"盘后"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RARE\",params:#limit:5,,,undefined,":[{"date":"2025-11-04","symbol":"RARE","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":-1.23,"defaultRemindTime":1762290000000,"name":null,"time":"Post Market","dateTimestamp":1762232400000,"actualEps":null},{"market":"US","date":"2025-08-05","symbol":"RARE","fiscalQuarterEnding":"2025/06","expectedEps":-1.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-06","symbol":"RARE","fiscalQuarterEnding":"2025/03","expectedEps":-1.54,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-1.57},{"market":"US","date":"2025-02-13","symbol":"RARE","fiscalQuarterEnding":"2024/12","expectedEps":-1.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-1.39},{"market":"US","date":"2025-01-12","symbol":"RARE","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1736658000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RARE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RARE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.619,"hold":0.0476,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.619,"analysts":21,"updateTime":1748491200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/RARE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"RARE","date":"2025-10-31","current":-6.265949,"percent":0.559378,"low":-57.721347,"twenty":-16.144099,"median":-6.798969,"eighty":-4.922401,"high":-3.237111,"avg":-11.967236,"sd":11.358038,"marketCap":3383305078},"quantilePoints":[{"date":"2020-11-06","current":-28.752844,"twenty":-30.231689,"median":-15.200985,"eighty":-8.83563,"marketCap":7371079013},{"date":"2020-11-13","current":-30.249581,"twenty":-30.174442,"median":-15.200985,"eighty":-8.83563,"marketCap":7754782641},{"date":"2020-11-20","current":-29.514115,"twenty":-30.01147,"median":-15.200985,"eighty":-8.83563,"marketCap":7566238617},{"date":"2020-11-27","current":-31.591484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8098792791},{"date":"2020-12-04","current":-33.168219,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":8503004716},{"date":"2020-12-11","current":-37.402954,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9588621362},{"date":"2020-12-18","current":-43.364099,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11116820295},{"date":"2020-12-24","current":-44.61052,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":11436352800},{"date":"2020-12-31","current":-35.722995,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9157947117},{"date":"2021-01-08","current":-38.860983,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9962401620},{"date":"2021-01-15","current":-35.604289,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9127515450},{"date":"2021-01-22","current":-36.249434,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9292904945},{"date":"2021-01-29","current":-35.764285,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9168532044},{"date":"2021-02-05","current":-41.8622,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10731793551},{"date":"2021-02-12","current":-53.920829,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":10059793403},{"date":"2021-02-19","current":-53.160067,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9917861006},{"date":"2021-02-26","current":-50.791655,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":9475995995},{"date":"2021-03-05","current":-42.523747,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7933485414},{"date":"2021-03-12","current":-45.556031,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8499206525},{"date":"2021-03-19","current":-44.759384,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":8350579204},{"date":"2021-03-26","current":-38.985484,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7273365868},{"date":"2021-04-01","current":-40.621841,"twenty":-29.968444,"median":-15.200985,"eighty":-8.83563,"marketCap":7578654420},{"date":"2021-04-09","current":-37.133817,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6927907769},{"date":"2021-04-16","current":-39.014192,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7278721807},{"date":"2021-04-23","current":-39.42687,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7355713438},{"date":"2021-04-30","current":-40.376431,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7532869144},{"date":"2021-05-07","current":-37.945412,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7728797410},{"date":"2021-05-14","current":-36.736115,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7482485435},{"date":"2021-05-21","current":-35.563263,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":7243596560},{"date":"2021-05-28","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-04","current":-30.543853,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6221233155},{"date":"2021-06-11","current":-33.697964,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6863668773},{"date":"2021-06-18","current":-31.448341,"twenty":-29.956039,"median":-15.161272,"eighty":-8.834973,"marketCap":6405461016},{"date":"2021-06-25","current":-31.087209,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":6331904837},{"date":"2021-07-02","current":-31.213108,"twenty":-30.257731,"median":-15.161272,"eighty":-8.834973,"marketCap":6357548275},{"date":"2021-07-09","current":-30.262236,"twenty":-30.265324,"median":-15.161272,"eighty":-8.834973,"marketCap":6163872832},{"date":"2021-07-16","current":-28.271038,"twenty":-30.233301,"median":-15.161272,"eighty":-8.834973,"marketCap":5758301606},{"date":"2021-07-23","current":-27.406308,"twenty":-29.984017,"median":-15.161272,"eighty":-8.834973,"marketCap":5582171673},{"date":"2021-07-30","current":-26.44881,"twenty":-29.79768,"median":-15.161272,"eighty":-8.834973,"marketCap":5387146575},{"date":"2021-08-06","current":-17.083279,"twenty":-29.687102,"median":-15.161272,"eighty":-8.834973,"marketCap":6003491310},{"date":"2021-08-13","current":-17.901732,"twenty":-29.496644,"median":-15.161272,"eighty":-8.834973,"marketCap":6291116204},{"date":"2021-08-20","current":-15.473397,"twenty":-29.315394,"median":-15.15171,"eighty":-8.834973,"marketCap":5437738569},{"date":"2021-08-27","current":-18.1353,"twenty":-29.179331,"median":-15.15171,"eighty":-8.834973,"marketCap":6373197837},{"date":"2021-09-03","current":-19.766415,"twenty":-28.984947,"median":-15.15171,"eighty":-8.834973,"marketCap":6946412544},{"date":"2021-09-10","current":-19.629363,"twenty":-28.634625,"median":-15.15171,"eighty":-8.834973,"marketCap":6898248941},{"date":"2021-09-17","current":-18.969196,"twenty":-28.497709,"median":-15.15171,"eighty":-8.834973,"marketCap":6666249616},{"date":"2021-09-24","current":-18.359217,"twenty":-28.236842,"median":-15.15171,"eighty":-8.834973,"marketCap":6451887666},{"date":"2021-10-01","current":-16.948157,"twenty":-28.151413,"median":-15.15171,"eighty":-8.834973,"marketCap":5956006068},{"date":"2021-10-08","current":-15.759084,"twenty":-28.053185,"median":-15.15171,"eighty":-8.834973,"marketCap":5538135938},{"date":"2021-10-15","current":-15.442512,"twenty":-27.812745,"median":-15.15171,"eighty":-8.834973,"marketCap":5426884800},{"date":"2021-10-22","current":-15.098916,"twenty":-27.55852,"median":-15.082382,"eighty":-8.834973,"marketCap":5306136613},{"date":"2021-10-29","current":-16.199195,"twenty":-27.366816,"median":-15.082382,"eighty":-8.834973,"marketCap":5692802155},{"date":"2021-11-05","current":-15.975791,"twenty":-27.236045,"median":-15.082382,"eighty":-8.834973,"marketCap":5680639831},{"date":"2021-11-12","current":-15.43713,"twenty":-27.171258,"median":-15.082382,"eighty":-8.834973,"marketCap":5489103979},{"date":"2021-11-19","current":-15.205181,"twenty":-26.927437,"median":-15.06031,"eighty":-8.834973,"marketCap":5406627687},{"date":"2021-11-26","current":-14.662686,"twenty":-26.731524,"median":-14.936554,"eighty":-8.834973,"marketCap":5213728590},{"date":"2021-12-03","current":-14.570673,"twenty":-26.554402,"median":-14.855697,"eighty":-8.834973,"marketCap":5181010722},{"date":"2021-12-10","current":-14.932975,"twenty":-26.360162,"median":-14.855697,"eighty":-8.834973,"marketCap":5309837327},{"date":"2021-12-17","current":-16.265249,"twenty":-26.205264,"median":-14.855697,"eighty":-8.834973,"marketCap":5783564791},{"date":"2021-12-23","current":-16.244163,"twenty":-25.908959,"median":-14.855697,"eighty":-8.834973,"marketCap":5776066946},{"date":"2021-12-31","current":-16.119562,"twenty":-25.241061,"median":-14.855697,"eighty":-8.834973,"marketCap":5731761500},{"date":"2022-01-07","current":-14.145112,"twenty":-24.735967,"median":-14.855038,"eighty":-8.83563,"marketCap":5029690582},{"date":"2022-01-14","current":-13.811564,"twenty":-24.180303,"median":-14.806289,"eighty":-8.83563,"marketCap":4911088311},{"date":"2022-01-21","current":-12.876097,"twenty":-23.989848,"median":-14.747324,"eighty":-8.83563,"marketCap":4578456653},{"date":"2022-01-28","current":-12.651814,"twenty":-23.661155,"median":-14.661474,"eighty":-8.83563,"marketCap":4498706850},{"date":"2022-02-04","current":-13.154053,"twenty":-23.48091,"median":-14.600648,"eighty":-8.83563,"marketCap":4677291879},{"date":"2022-02-11","current":-10.94589,"twenty":-23.205637,"median":-14.505395,"eighty":-8.83563,"marketCap":4969707824},{"date":"2022-02-18","current":-10.194721,"twenty":-23.125145,"median":-14.35823,"eighty":-8.83563,"marketCap":4628658273},{"date":"2022-02-25","current":-10.307809,"twenty":-22.914219,"median":-14.283419,"eighty":-8.83563,"marketCap":4680003006},{"date":"2022-03-04","current":-9.594133,"twenty":-22.459434,"median":-14.16111,"eighty":-8.83563,"marketCap":4355976111},{"date":"2022-03-11","current":-9.996053,"twenty":-21.586553,"median":-14.118393,"eighty":-8.83563,"marketCap":4538458067},{"date":"2022-03-18","current":-10.663883,"twenty":-21.326675,"median":-14.069914,"eighty":-8.83563,"marketCap":4841669529},{"date":"2022-03-25","current":-10.524816,"twenty":-21.159681,"median":-13.968769,"eighty":-8.83563,"marketCap":4778529385},{"date":"2022-04-01","current":-11.823798,"twenty":-21.003206,"median":-13.863231,"eighty":-8.83563,"marketCap":5368299964},{"date":"2022-04-08","current":-12.514551,"twenty":-20.910296,"median":-13.803148,"eighty":-8.83563,"marketCap":5681919142},{"date":"2022-04-14","current":-13.050955,"twenty":-20.848103,"median":-13.773354,"eighty":-8.83563,"marketCap":5925459699},{"date":"2022-04-22","current":-11.470781,"twenty":-20.717776,"median":-13.670793,"eighty":-8.83563,"marketCap":5208021136},{"date":"2022-04-29","current":-10.878745,"twenty":-20.624785,"median":-13.564241,"eighty":-8.83563,"marketCap":4939222202},{"date":"2022-05-06","current":-8.557526,"twenty":-20.519008,"median":-13.487652,"eighty":-8.833003,"marketCap":4023783190},{"date":"2022-05-13","current":-7.654777,"twenty":-20.519008,"median":-13.402239,"eighty":-8.786823,"marketCap":3599306930},{"date":"2022-05-20","current":-7.220506,"twenty":-20.519008,"median":-13.35812,"eighty":-8.748709,"marketCap":3395110773},{"date":"2022-05-27","current":-7.233891,"twenty":-20.519008,"median":-13.323757,"eighty":-8.718034,"marketCap":3401404490},{"date":"2022-06-03","current":-7.645854,"twenty":-20.519008,"median":-13.277877,"eighty":-8.684283,"marketCap":3595111119},{"date":"2022-06-10","current":-7.418308,"twenty":-20.519008,"median":-13.17025,"eighty":-8.65258,"marketCap":3488117927},{"date":"2022-06-17","current":-7.925453,"twenty":-20.519008,"median":-13.057111,"eighty":-8.633594,"marketCap":3726579878},{"date":"2022-06-24","current":-9.008157,"twenty":-20.52732,"median":-13.025475,"eighty":-8.615488,"marketCap":4235671668},{"date":"2022-07-01","current":-9.317501,"twenty":-20.52732,"median":-12.971944,"eighty":-8.615488,"marketCap":4381126466},{"date":"2022-07-08","current":-9.836545,"twenty":-20.52732,"median":-12.903988,"eighty":-8.615488,"marketCap":4625182832},{"date":"2022-07-15","current":-9.62982,"twenty":-20.52732,"median":-12.867014,"eighty":-8.615488,"marketCap":4527979867},{"date":"2022-07-22","current":-7.657752,"twenty":-20.52732,"median":-12.683542,"eighty":-8.593044,"marketCap":3600705534},{"date":"2022-07-29","current":-7.375537,"twenty":-20.52732,"median":-12.576503,"eighty":-8.565198,"marketCap":3731564327},{"date":"2022-08-05","current":-7.696694,"twenty":-20.52732,"median":-12.447093,"eighty":-8.50432,"marketCap":3894049860},{"date":"2022-08-12","current":-7.138822,"twenty":-20.52732,"median":-12.354843,"eighty":-8.455092,"marketCap":3611801282},{"date":"2022-08-19","current":-6.78721,"twenty":-20.52732,"median":-12.331685,"eighty":-8.434672,"marketCap":3433907638},{"date":"2022-08-26","current":-6.852272,"twenty":-20.52732,"median":-12.331685,"eighty":-8.389678,"marketCap":3466824966},{"date":"2022-09-02","current":-6.61002,"twenty":-20.52732,"median":-12.331685,"eighty":-8.359036,"marketCap":3344260447},{"date":"2022-09-09","current":-6.816281,"twenty":-20.52732,"median":-12.331685,"eighty":-8.331801,"marketCap":3448615380},{"date":"2022-09-16","current":-6.371921,"twenty":-20.52732,"median":-12.331685,"eighty":-8.289414,"marketCap":3223797034},{"date":"2022-09-23","current":-5.744834,"twenty":-20.52732,"median":-12.331685,"eighty":-8.245615,"marketCap":2906530022},{"date":"2022-09-30","current":-5.732376,"twenty":-20.52732,"median":-12.331685,"eighty":-8.208124,"marketCap":2900226703},{"date":"2022-10-07","current":-5.25064,"twenty":-20.52732,"median":-12.331685,"eighty":-8.150659,"marketCap":2656498403},{"date":"2022-10-14","current":-5.130206,"twenty":-20.52732,"median":-12.331685,"eighty":-8.077486,"marketCap":2595566328},{"date":"2022-10-21","current":-5.328161,"twenty":-20.52732,"median":-12.331685,"eighty":-8.010065,"marketCap":2695719049},{"date":"2022-10-28","current":-5.642396,"twenty":-20.52732,"median":-12.331685,"eighty":-7.967887,"marketCap":2854702739},{"date":"2022-11-04","current":-3.646694,"twenty":-20.52732,"median":-12.331685,"eighty":-7.881082,"marketCap":2472626416},{"date":"2022-11-11","current":-3.779038,"twenty":-20.52732,"median":-12.331685,"eighty":-7.854126,"marketCap":2562361653},{"date":"2022-11-18","current":-3.721138,"twenty":-20.52732,"median":-12.331685,"eighty":-7.7969,"marketCap":2523102487},{"date":"2022-11-25","current":-3.693221,"twenty":-20.52732,"median":-12.331685,"eighty":-7.738619,"marketCap":2504173960},{"date":"2022-12-02","current":-4.153323,"twenty":-20.52732,"median":-12.331685,"eighty":-7.69117,"marketCap":2816144121},{"date":"2022-12-09","current":-4.202952,"twenty":-20.52732,"median":-12.331685,"eighty":-7.649461,"marketCap":2849794835},{"date":"2022-12-16","current":-4.717852,"twenty":-20.52732,"median":-12.331685,"eighty":-7.588745,"marketCap":3198920992},{"date":"2022-12-23","current":-4.499692,"twenty":-20.52732,"median":-12.331685,"eighty":-7.55634,"marketCap":3050998062},{"date":"2022-12-30","current":-4.790228,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3247994949},{"date":"2023-01-06","current":-4.824348,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3271129815},{"date":"2023-01-13","current":-4.502794,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":3053101231},{"date":"2023-01-20","current":-4.383891,"twenty":-20.52732,"median":-12.331685,"eighty":-7.468808,"marketCap":2972479729},{"date":"2023-01-27","current":-4.520371,"twenty":-20.52732,"median":-12.331685,"eighty":-7.419224,"marketCap":3065019192},{"date":"2023-02-03","current":-4.728192,"twenty":-20.52732,"median":-12.331685,"eighty":-7.265696,"marketCap":3205931557},{"date":"2023-02-10","current":-4.549321,"twenty":-20.52732,"median":-12.331685,"eighty":-7.228067,"marketCap":3084648776},{"date":"2023-02-17","current":-4.834822,"twenty":-20.52732,"median":-12.331685,"eighty":-7.193971,"marketCap":3420254921},{"date":"2023-02-24","current":-4.342506,"twenty":-20.52732,"median":-12.331685,"eighty":-7.118611,"marketCap":3071980143},{"date":"2023-03-03","current":-4.536058,"twenty":-20.52732,"median":-12.331685,"eighty":-7.091607,"marketCap":3208902687},{"date":"2023-03-10","current":-3.847212,"twenty":-20.52732,"median":-12.331685,"eighty":-7.007538,"marketCap":2721598865},{"date":"2023-03-17","current":-3.824383,"twenty":-20.52732,"median":-12.331685,"eighty":-6.964752,"marketCap":2705449027},{"date":"2023-03-24","current":-3.740015,"twenty":-20.52732,"median":-12.331685,"eighty":-6.882782,"marketCap":2645764841},{"date":"2023-03-31","current":-3.980217,"twenty":-20.519008,"median":-12.327325,"eighty":-6.84769,"marketCap":2815689228},{"date":"2023-04-06","current":-3.845227,"twenty":-20.519008,"median":-12.327325,"eighty":-6.817229,"marketCap":2720194531},{"date":"2023-04-14","current":-3.834309,"twenty":-20.52732,"median":-12.331685,"eighty":-6.790561,"marketCap":2712470696},{"date":"2023-04-21","current":-4.095356,"twenty":-20.52732,"median":-12.331685,"eighty":-6.741883,"marketCap":2897140588},{"date":"2023-04-28","current":-4.242476,"twenty":-20.52732,"median":-12.331685,"eighty":-6.708105,"marketCap":3001216442},{"date":"2023-05-05","current":-4.503028,"twenty":-20.52732,"median":-12.331685,"eighty":-6.653176,"marketCap":3238005775},{"date":"2023-05-12","current":-4.638891,"twenty":-20.543943,"median":-12.127091,"eighty":-6.641982,"marketCap":3335701281},{"date":"2023-05-19","current":-5.014059,"twenty":-20.543943,"median":-12.030107,"eighty":-6.608226,"marketCap":3605474618},{"date":"2023-05-26","current":-4.91559,"twenty":-20.543943,"median":-11.942999,"eighty":-6.574925,"marketCap":3534667968},{"date":"2023-06-02","current":-4.885064,"twenty":-20.543943,"median":-11.851539,"eighty":-6.547631,"marketCap":3512717906},{"date":"2023-06-09","current":-5.079049,"twenty":-20.543943,"median":-11.661746,"eighty":-6.51973,"marketCap":3652207007},{"date":"2023-06-16","current":-4.811212,"twenty":-20.543943,"median":-11.483123,"eighty":-6.479975,"marketCap":3459612919},{"date":"2023-06-21","current":-4.936268,"twenty":-20.510696,"median":-11.421308,"eighty":-6.417082,"marketCap":3549537364},{"date":"2023-06-30","current":-4.593595,"twenty":-20.487227,"median":-11.238841,"eighty":-6.371161,"marketCap":3303130222},{"date":"2023-07-07","current":-4.482325,"twenty":-20.498962,"median":-11.187498,"eighty":-6.365701,"marketCap":3223118708},{"date":"2023-07-21","current":-4.237136,"twenty":-19.951513,"median":-11.097535,"eighty":-6.330057,"marketCap":3046810149},{"date":"2023-07-28","current":-4.134728,"twenty":-19.945557,"median":-11.07773,"eighty":-6.267685,"marketCap":2973171233},{"date":"2023-08-04","current":-4.057384,"twenty":-19.897508,"median":-11.023587,"eighty":-6.244893,"marketCap":2924314645},{"date":"2023-08-11","current":-3.621915,"twenty":-19.755822,"median":-10.996766,"eighty":-6.219342,"marketCap":2610455224},{"date":"2023-08-18","current":-3.463233,"twenty":-19.719512,"median":-10.937719,"eighty":-6.110593,"marketCap":2496086977},{"date":"2023-08-25","current":-3.666544,"twenty":-19.634346,"median":-10.899761,"eighty":-5.986933,"marketCap":2642621293},{"date":"2023-09-01","current":-3.648692,"twenty":-19.538575,"median":-10.863505,"eighty":-5.82457,"marketCap":2629754865},{"date":"2023-09-08","current":-4.080109,"twenty":-19.362208,"median":-10.802755,"eighty":-5.750563,"marketCap":2940693535},{"date":"2023-09-15","current":-3.893658,"twenty":-19.077218,"median":-10.732491,"eighty":-5.672427,"marketCap":2806310846},{"date":"2023-09-22","current":-3.630841,"twenty":-18.981061,"median":-10.679378,"eighty":-5.619716,"marketCap":2616888437},{"date":"2023-09-29","current":-3.488027,"twenty":-18.845186,"median":-10.612101,"eighty":-5.581034,"marketCap":2513957016},{"date":"2023-10-06","current":-3.468192,"twenty":-18.69861,"median":-10.535971,"eighty":-5.490331,"marketCap":2499660985},{"date":"2023-10-13","current":-3.237111,"twenty":-18.632497,"median":-10.521807,"eighty":-5.460417,"marketCap":2333112226},{"date":"2023-10-20","current":-3.7042,"twenty":-18.632497,"median":-10.443907,"eighty":-5.405085,"marketCap":2669761173},{"date":"2023-10-27","current":-3.893405,"twenty":-18.654427,"median":-10.382839,"eighty":-5.365218,"marketCap":2806128470},{"date":"2023-11-03","current":-4.68465,"twenty":-18.654427,"median":-10.364295,"eighty":-5.28414,"marketCap":2976073660},{"date":"2023-11-10","current":-4.517051,"twenty":-18.654427,"median":-10.342873,"eighty":-5.170628,"marketCap":2869601414},{"date":"2023-11-17","current":-5.034024,"twenty":-18.654427,"median":-10.305516,"eighty":-5.093229,"marketCap":3198025038},{"date":"2023-11-24","current":-5.058581,"twenty":-18.654427,"median":-10.281065,"eighty":-5.066839,"marketCap":3213625160},{"date":"2023-12-01","current":-5.0211,"twenty":-18.654427,"median":-10.19999,"eighty":-5.05703,"marketCap":3189814448},{"date":"2023-12-08","current":-5.353255,"twenty":-18.644324,"median":-10.171258,"eighty":-5.057805,"marketCap":3400826626},{"date":"2023-12-15","current":-5.933557,"twenty":-18.644324,"median":-10.119914,"eighty":-5.057805,"marketCap":3769482144},{"date":"2023-12-22","current":-5.885737,"twenty":-18.644324,"median":-10.02608,"eighty":-5.057805,"marketCap":3739102959},{"date":"2023-12-29","current":-6.238571,"twenty":-18.654427,"median":-9.99662,"eighty":-5.05703,"marketCap":3963252082},{"date":"2024-01-05","current":-6.086064,"twenty":-18.664531,"median":-9.939328,"eighty":-5.056254,"marketCap":3866367113},{"date":"2024-01-12","current":-5.964576,"twenty":-18.664531,"median":-9.900378,"eighty":-5.056254,"marketCap":3789187561},{"date":"2024-01-19","current":-5.578138,"twenty":-18.674634,"median":-9.811733,"eighty":-5.055479,"marketCap":3543690902},{"date":"2024-01-26","current":-5.848257,"twenty":-18.664531,"median":-9.7849,"eighty":-5.056254,"marketCap":3715292246},{"date":"2024-02-02","current":-5.699627,"twenty":-18.664531,"median":-9.642907,"eighty":-5.056254,"marketCap":3620870454},{"date":"2024-02-09","current":-5.874105,"twenty":-18.664531,"median":-9.594133,"eighty":-5.056254,"marketCap":3731713427},{"date":"2024-02-16","current":-6.261086,"twenty":-18.664531,"median":-9.561842,"eighty":-5.056254,"marketCap":3798219211},{"date":"2024-02-23","current":-6.634206,"twenty":-18.664531,"median":-9.488533,"eighty":-5.056254,"marketCap":4024568380},{"date":"2024-03-01","current":-7.019664,"twenty":-18.654427,"median":-9.448218,"eighty":-5.05703,"marketCap":4258401731},{"date":"2024-03-08","current":-6.901583,"twenty":-18.618504,"median":-9.331505,"eighty":-5.05703,"marketCap":4186769683},{"date":"2024-03-15","current":-6.331541,"twenty":-18.555722,"median":-9.248631,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-22","current":-6.331541,"twenty":-18.362305,"median":-9.119934,"eighty":-5.05703,"marketCap":3840959798},{"date":"2024-03-28","current":-6.354614,"twenty":-18.110177,"median":-9.054151,"eighty":-5.05703,"marketCap":3854956865},{"date":"2024-04-05","current":-6.389903,"twenty":-17.885675,"median":-8.975116,"eighty":-5.056254,"marketCap":3876364143},{"date":"2024-04-12","current":-6.881225,"twenty":-17.643907,"median":-8.928874,"eighty":-5.056254,"marketCap":4174419330},{"date":"2024-04-19","current":-5.887723,"twenty":-17.405641,"median":-8.865305,"eighty":-5.056254,"marketCap":3571722102},{"date":"2024-04-26","current":-5.951513,"twenty":-17.24545,"median":-8.784804,"eighty":-5.05703,"marketCap":3610419874},{"date":"2024-05-03","current":-5.85531,"twenty":-17.111877,"median":-8.730843,"eighty":-5.05703,"marketCap":3591360331},{"date":"2024-05-10","current":-5.582669,"twenty":-17.109146,"median":-8.602772,"eighty":-5.05703,"marketCap":3424135754},{"date":"2024-05-17","current":-5.770925,"twenty":-17.109146,"median":-8.502293,"eighty":-5.05703,"marketCap":3539602729},{"date":"2024-05-24","current":-5.403894,"twenty":-17.109146,"median":-8.437742,"eighty":-5.05703,"marketCap":3314483663},{"date":"2024-05-31","current":-5.234599,"twenty":-17.109146,"median":-8.326018,"eighty":-5.05703,"marketCap":3210646455},{"date":"2024-06-07","current":-5.657159,"twenty":-17.109146,"median":-8.22856,"eighty":-5.05703,"marketCap":3469824125},{"date":"2024-06-14","current":-6.362758,"twenty":-17.109548,"median":-8.139615,"eighty":-5.056254,"marketCap":3902604231},{"date":"2024-06-21","current":-5.610206,"twenty":-17.10995,"median":-8.062414,"eighty":-5.055479,"marketCap":3441025345},{"date":"2024-06-28","current":-6.111908,"twenty":-17.111877,"median":-7.980946,"eighty":-5.053152,"marketCap":3748744602},{"date":"2024-07-05","current":-5.933361,"twenty":-17.111877,"median":-7.91653,"eighty":-5.053152,"marketCap":3639232749},{"date":"2024-07-12","current":-6.476379,"twenty":-17.111877,"median":-7.842615,"eighty":-5.053152,"marketCap":3972293592},{"date":"2024-07-15","current":-6.660828,"twenty":-17.111877,"median":-7.815809,"eighty":-5.053152,"marketCap":4085425672},{"date":"2024-08-02","current":-6.829058,"twenty":-17.121885,"median":-7.700275,"eighty":-5.034024,"marketCap":3995825065},{"date":"2024-08-09","current":-7.915825,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4631715386},{"date":"2024-08-16","current":-8.142486,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":4764339569},{"date":"2024-08-23","current":-8.871265,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5190763157},{"date":"2024-08-30","current":-8.965707,"twenty":-17.121885,"median":-7.700012,"eighty":-5.034024,"marketCap":5246023233},{"date":"2024-09-06","current":-8.885431,"twenty":-17.121885,"median":-7.70624,"eighty":-5.034024,"marketCap":5199052169},{"date":"2024-09-13","current":-9.102648,"twenty":-17.121885,"median":-7.774964,"eighty":-5.034024,"marketCap":5326150344},{"date":"2024-09-20","current":-9.252181,"twenty":-17.121885,"median":-7.849896,"eighty":-5.034024,"marketCap":5413645465},{"date":"2024-09-27","current":-8.691824,"twenty":-17.121885,"median":-7.916177,"eighty":-5.034024,"marketCap":5085769012},{"date":"2024-10-04","current":-8.446275,"twenty":-17.121885,"median":-7.994412,"eighty":-5.034024,"marketCap":4942092814},{"date":"2024-10-11","current":-8.47933,"twenty":-17.121885,"median":-8.063851,"eighty":-5.034024,"marketCap":4961433841},{"date":"2024-10-18","current":-8.9358,"twenty":-17.121885,"median":-8.144847,"eighty":-5.034024,"marketCap":5228524209},{"date":"2024-10-25","current":-8.628863,"twenty":-17.121885,"median":-8.21254,"eighty":-5.034024,"marketCap":5048928962},{"date":"2024-10-31","current":-8.1598,"twenty":-17.121885,"median":-8.258605,"eighty":-5.034024,"marketCap":4774470583},{"date":"2024-11-08","current":-8.324768,"twenty":-17.142899,"median":-8.319439,"eighty":-5.03169,"marketCap":4653445648},{"date":"2024-11-15","current":-7.864207,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395997435},{"date":"2024-11-22","current":-7.596785,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4246511376},{"date":"2024-11-29","current":-7.862556,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4395074682},{"date":"2024-12-06","current":-7.814684,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4368314832},{"date":"2024-12-13","current":-7.7404,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4326790927},{"date":"2024-12-20","current":-7.175841,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4011209247},{"date":"2024-12-27","current":-7.233618,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":4043505617},{"date":"2025-01-03","current":-6.792866,"twenty":-17.142899,"median":-8.324768,"eighty":-5.03169,"marketCap":3797130446},{"date":"2025-01-10","current":-7.205555,"twenty":-17.163913,"median":-8.328682,"eighty":-5.029355,"marketCap":4027818809},{"date":"2025-01-17","current":-6.743343,"twenty":-17.163913,"median":-8.303187,"eighty":-5.029355,"marketCap":3769447843},{"date":"2025-01-24","current":-7.403646,"twenty":-17.163913,"median":-8.22856,"eighty":-5.029355,"marketCap":4138549223},{"date":"2025-01-31","current":-7.164286,"twenty":-17.163913,"median":-8.210902,"eighty":-5.029355,"marketCap":4004749973},{"date":"2025-02-07","current":-7.557166,"twenty":-17.163913,"median":-8.156652,"eighty":-5.029355,"marketCap":4224365294},{"date":"2025-02-14","current":-7.055416,"twenty":-17.163913,"median":-8.140574,"eighty":-5.029355,"marketCap":4015823014},{"date":"2025-02-21","current":-7.228695,"twenty":-17.163913,"median":-8.07435,"eighty":-5.029355,"marketCap":4114450084},{"date":"2025-02-28","current":-6.82078,"twenty":-17.163913,"median":-8.063851,"eighty":-5.029355,"marketCap":3882272258},{"date":"2025-03-07","current":-6.503875,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3701895062},{"date":"2025-03-14","current":-6.378738,"twenty":-17.184926,"median":-8.040838,"eighty":-5.027021,"marketCap":3630669195},{"date":"2025-03-21","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-03-28","current":-6.320232,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3597368790},{"date":"2025-04-04","current":-5.709174,"twenty":-17.184926,"median":-8.040838,"eighty":-5.048263,"marketCap":3249564556},{"date":"2025-04-11","current":-5.389018,"twenty":-17.163913,"median":-8.038932,"eighty":-5.047263,"marketCap":3067337338},{"date":"2025-04-17","current":-5.770746,"twenty":-17.163913,"median":-7.988725,"eighty":-5.047263,"marketCap":3284610351},{"date":"2025-04-25","current":-6.209573,"twenty":-17.184926,"median":-7.897222,"eighty":-5.047026,"marketCap":3534383465},{"date":"2025-05-02","current":-6.428987,"twenty":-17.184926,"median":-7.862556,"eighty":-5.047026,"marketCap":3659270022},{"date":"2025-05-09","current":-6.178877,"twenty":-17.184926,"median":-7.798177,"eighty":-5.047026,"marketCap":3395781282},{"date":"2025-05-16","current":-5.983104,"twenty":-17.184926,"median":-7.720227,"eighty":-5.047026,"marketCap":3288188434},{"date":"2025-05-23","current":-6.098164,"twenty":-17.184926,"median":-7.659513,"eighty":-5.047026,"marketCap":3351422827},{"date":"2025-05-30","current":-6.015733,"twenty":-17.184926,"median":-7.598263,"eighty":-5.047026,"marketCap":3306120575},{"date":"2025-06-06","current":-6.338587,"twenty":-17.184926,"median":-7.557166,"eighty":-5.047026,"marketCap":3483554394},{"date":"2025-06-13","current":-6.747307,"twenty":-17.184926,"median":-7.489485,"eighty":-5.047026,"marketCap":3708178059},{"date":"2025-06-20","current":-6.414149,"twenty":-17.20594,"median":-7.434667,"eighty":-5.04679,"marketCap":3525081458},{"date":"2025-06-27","current":-6.374651,"twenty":-17.20594,"median":-7.397868,"eighty":-5.04679,"marketCap":3503374129},{"date":"2025-07-03","current":-6.85378,"twenty":-17.20594,"median":-7.331032,"eighty":-5.04679,"marketCap":3766693467},{"date":"2025-07-11","current":-5.329668,"twenty":-17.20594,"median":-7.284263,"eighty":-5.04679,"marketCap":2929073710},{"date":"2025-07-18","current":-4.707144,"twenty":-17.20594,"median":-7.231156,"eighty":-5.019717,"marketCap":2586947330},{"date":"2025-07-25","current":-4.688253,"twenty":-17.20594,"median":-7.2205,"eighty":-4.990742,"marketCap":2576565564},{"date":"2025-08-01","current":-4.691688,"twenty":-17.20594,"median":-7.178045,"eighty":-4.933118,"marketCap":2578453158},{"date":"2025-08-08","current":-5.023544,"twenty":-17.20594,"median":-7.165937,"eighty":-4.922401,"marketCap":2677207288},{"date":"2025-08-15","current":-5.236544,"twenty":-17.120341,"median":-7.127226,"eighty":-4.922401,"marketCap":2790721647},{"date":"2025-08-22","current":-5.328603,"twenty":-16.992353,"median":-7.100943,"eighty":-4.922401,"marketCap":2839782937},{"date":"2025-08-29","current":-5.469399,"twenty":-16.931942,"median":-7.088351,"eighty":-4.922401,"marketCap":2914817852},{"date":"2025-09-05","current":-5.646297,"twenty":-16.867084,"median":-7.050962,"eighty":-4.921583,"marketCap":3009092489},{"date":"2025-09-12","current":-5.637272,"twenty":-16.862117,"median":-7.009732,"eighty":-4.922401,"marketCap":3004282559},{"date":"2025-09-19","current":-5.254594,"twenty":-16.862117,"median":-6.97646,"eighty":-4.922401,"marketCap":2800341507},{"date":"2025-09-26","current":-5.021739,"twenty":-16.862117,"median":-6.933137,"eighty":-4.922401,"marketCap":2676245302},{"date":"2025-10-03","current":-5.577704,"twenty":-16.789633,"median":-6.862153,"eighty":-4.922401,"marketCap":2972537018},{"date":"2025-10-10","current":-5.71489,"twenty":-16.494533,"median":-6.851457,"eighty":-4.922401,"marketCap":3045647960},{"date":"2025-10-17","current":-6.131864,"twenty":-16.395701,"median":-6.820464,"eighty":-4.922401,"marketCap":3267866747},{"date":"2025-10-24","current":-6.070492,"twenty":-16.196687,"median":-6.815304,"eighty":-4.922401,"marketCap":3235159220},{"date":"2025-10-31","current":-6.348474,"twenty":-16.144099,"median":-6.798969,"eighty":-4.922401,"marketCap":3383305078}],"updateTime":1762094779959},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RARE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2579127288","title":"Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Exelixis (EXEL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2579127288","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579127288?lang=en_us&edition=fundamental","pubTime":"2025-10-31 00:40","pubTimestamp":1761842410,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ultragenyx Pharmaceutical (RARE – Research Report) a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-exelixis-exel-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ultragenyx-pharmaceutical-rare-and-exelixis-exel-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","BK4581","BK4585","XBI","BK4137","LU0029874061.USD","BK4532","RARE","BK4139","EXEL","LU0128526141.USD","BK4588","LABU","HCSG"],"gpt_icon":0},{"id":"2579514991","title":"Ultragenyx announces first patient dosed in Aurora study","url":"https://stock-news.laohu8.com/highlight/detail?id=2579514991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579514991?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:10","pubTimestamp":1761826220,"startTime":"0","endTime":"0","summary":"Ultragenyx (RARE) Pharmaceutical announced that the first patient has been dosed in the Aurora study evaluating the efficacy and safety of GTX-102,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-announces-first-patient-dosed-in-aurora-study-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-announces-first-patient-dosed-in-aurora-study-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","ACB","RARE","BK4557","BK4139"],"gpt_icon":0},{"id":"2579146849","title":"Ultragenyx Doses First Patient in Aurora Trial for Angelman Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2579146849","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579146849?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:01","pubTimestamp":1761825682,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. announced that the first patient has been dosed in the Aurora study, which is evaluating the efficacy and safety of GTX-102 , an investigational treatment for Angelman syndrome. The Aurora study will enroll approximately 60 participants aged 1 to under 65 years old with Angelman syndrome across all genotypes, expanding the population studied beyond the previous Phase 3 Aspire trial. The Aurora study features four cohorts based on age and genotype, with varying primary endpoints, and includes both single-arm and randomized groups. The Aspire Phase 3 study, focused on patients aged 4 to 17 years with full maternal UBE3A gene deletion, has completed enrollment, with results expected in the second half of 2026. No new research results have been presented yet; current announcements pertain to trial enrollment and study initiation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL7Pwzgs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4112","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LU2095319765.USD","LU0314104364.USD","BK4139","IE00BGHQF748.EUR","BK4588","LU2210150020.SGD","LU2210149790.SGD","NDAQ","IE00B64PRP62.GBP","RARE"],"gpt_icon":0},{"id":"2579145215","title":"Ultragenyx Announces First Patient Dosed in Aurora Study Evaluating Gtx-102 in Additional Angelman Syndrome Genotypes and Age Groups","url":"https://stock-news.laohu8.com/highlight/detail?id=2579145215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579145215?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:00","pubTimestamp":1761825608,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUA8NR9S8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2579773994","title":"Ultragenyx Pharmaceutical Inc. to Release Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579773994","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579773994?lang=en_us&edition=fundamental","pubTime":"2025-10-29 04:30","pubTimestamp":1761683436,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  on October 28, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251028:nNDLbRVP8R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4112","IE00BKPKM429.USD","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2095319765.USD","LU2210149790.SGD","BK4585","LU0314104364.USD","BK4588","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","RARE"],"gpt_icon":0},{"id":"2578540167","title":"Ultragenyx Grants Restricted Stock Units to New Hires Under Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540167","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540167?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:30","pubTimestamp":1761337808,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. has announced the grant of 20,317 restricted stock units to 17 newly hired non-executive officers. The awards, granted under the Ultragenyx Employment Inducement Plan, will vest over four years, with 25% of the shares vesting on each anniversary of the grant date, provided the employee remains continuously employed by the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  on October 24, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nNDL6fyVSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","BK4585","LU2210150020.SGD","IE00B64PRP62.GBP","LU2095319765.USD","LU2210149790.SGD","BK4139","NDAQ","RARE","IE00B3QW5Z07.USD","BK4112","IE00BKPKM429.USD","IE00BGHQF748.EUR","BK4588"],"gpt_icon":0},{"id":"2578540156","title":"Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540156","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540156?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:30","pubTimestamp":1761337800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251024:nTUA4WBPCY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2578540193","title":"Press Release: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2578540193","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578540193?lang=en_us&edition=fundamental","pubTime":"2025-10-25 04:30","pubTimestamp":1761337800,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., Oct. 24, 2025  -- Ultragenyx Pharmaceutical Inc. , a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 20,317 restricted stock units of the company's common stock to 17 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company's board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of October 16, 2025, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635.The restricted stock units vest over four years, with 25% of the underlying shares vesting on each anniversary of the grant date, subject to the employee being continuously employed by the company as of such vesting dates.The company is led by a management team experienced in the development and commercialization of rare disease ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","QLD",".IXIC","BK4139","USAW.SI","NVIW.SI","QID","SQQQ","TSYW.SI","PSQ","NQmain","MNQmain","TQQQ","RARE"],"gpt_icon":1},{"id":"2577399781","title":"Ultragenyx price target lowered to $74 from $79 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2577399781","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577399781?lang=en_us&edition=fundamental","pubTime":"2025-10-22 23:30","pubTimestamp":1761147029,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Ultragenyx (RARE) to $74 from $79 and keeps a Buy rating on the shares. The firm adjusted targets among its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-lowered-to-74-from-79-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-price-target-lowered-to-74-from-79-at-bofa-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2577314395","title":"BofA Securities Adjusts Ultragenyx Pharmaceutical Price Target to $74 From $79, Maintains Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2577314395","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577314395?lang=en_us&edition=fundamental","pubTime":"2025-10-22 22:17","pubTimestamp":1761142644,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (RARE) has an average rating of Buy and mean price target of $85.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE"],"gpt_icon":0},{"id":"2577641398","title":"Ultragenyx Pharmaceutical Inc : Bofa Global Research Cuts Price Objective to $74 From $79","url":"https://stock-news.laohu8.com/highlight/detail?id=2577641398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577641398?lang=en_us&edition=fundamental","pubTime":"2025-10-22 21:48","pubTimestamp":1761140929,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W338P:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RARE","BK4139"],"gpt_icon":0},{"id":"2575292464","title":"Wedbush Lifts Price Target on Ultragenyx Pharmaceutical to $35 From $34, Keeps Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2575292464","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575292464?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:40","pubTimestamp":1760442046,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical (RARE) has an average rating of buy and mean price target of $86.10, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RARE"],"gpt_icon":0},{"id":"2572633733","title":"Ultragenyx Grants Stock Options and RSUs to New Hire Under Inducement Plan Approved by Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2572633733","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572633733?lang=en_us&edition=fundamental","pubTime":"2025-10-04 04:30","pubTimestamp":1759523408,"startTime":"0","endTime":"0","summary":"Ultragenyx Pharmaceutical Inc. has announced the grant of non-qualified stock options and restricted stock units to a newly hired non-executive officer employee. The employee has received options to purchase 62,232 shares of common stock at an exercise price of $30.08 per share, along with 34,564 restricted stock units. The stock options will vest over four years, with 25% vesting after one year and the remainder vesting monthly thereafter. The restricted stock units will vest in equal annual installments over four years. The grant date for these awards was September 30, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via GlobeNewswire  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL6WWk7b:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","LU2210150020.SGD","RARE","BK4585","LU2210149790.SGD","IE00B64PRP62.GBP","BK4588","LU0314104364.USD","BK4112","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2572963562","title":"Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2572963562","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572963562?lang=en_us&edition=fundamental","pubTime":"2025-10-04 04:30","pubTimestamp":1759523400,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., Oct.  03, 2025  (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for r","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/03/3161217/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVIW.SI","MNQmain","QID","TSYW.SI","RARE","TQQQ","PSQ","NQmain","QLD","USJW.SI","BK4139","SQQQ",".IXIC","USAW.SI"],"gpt_icon":1},{"id":"2572519623","title":"Ultragenyx placed on ‘Positive Catalyst Watch’ at JPMorgan","url":"https://stock-news.laohu8.com/highlight/detail?id=2572519623","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572519623?lang=en_us&edition=fundamental","pubTime":"2025-10-02 18:55","pubTimestamp":1759402524,"startTime":"0","endTime":"0","summary":"JPMorgan analyst Anupam Rama placed shares of Ultragenyx (RARE) on “Positive Catalyst Watch” ahead of the company’s ORBIT and COSMIC study updates....","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ultragenyx-placed-on-positive-catalyst-watch-at-jpmorgan-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ultragenyx-placed-on-positive-catalyst-watch-at-jpmorgan-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2430703251.USD","LU0211327993.USD","LU2237443465.HKD","IE00BYXW3230.USD","LU1119994496.HKD","LU0345770308.USD","IE00BJLML261.HKD","LU2106854487.HKD","LU2237443382.USD","LU2357305700.SGD","LU0310799852.SGD","LU1720051017.SGD","LU0208291251.USD","LU2756315318.SGD","RARE","LU1244550494.USD","LU2213496289.HKD","LU0006306889.USD","LU1496350171.SGD","JPM","IE00BLSP4452.SGD","LU2237443978.SGD","IE00BJTD4V19.USD","BK4504","IE00BKDWB100.SGD","LU1668664300.SGD","BK4534","LU1720051108.HKD","LU1280957306.USD","LU1244550221.USD","LU2456880835.USD","LU2505996509.AUD","SG9999002232.USD","BK4588","LU0345769128.USD","LU1145028129.USD","IE00BWXC8680.SGD","LU0215105999.USD","IE00BDRTCR15.USD","LU2505996681.GBP","IE00B775SV38.USD","BK4585","LU0070302665.USD","BK4207","IE00BDCRKT87.USD","LU2237443622.USD","LU2417539215.USD","LU0149725797.USD","IE00BFXG1179.USD","IE00BN8TJ469.HKD"],"gpt_icon":0},{"id":"2572371863","title":"Press Release: Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President","url":"https://stock-news.laohu8.com/highlight/detail?id=2572371863","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572371863?lang=en_us&edition=fundamental","pubTime":"2025-10-01 04:05","pubTimestamp":1759262700,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., Sept. 30, 2025  -- Ultragenyx Pharmaceutical Inc.  today announced the appointment of Eric Olson as chief business officer  and executive vice president effective September 22, 2025, following the planned retirement of Thomas Kassberg. Mr. Olson will be responsible for leading the company's business development, corporate development and alliance management functions.\"Ultragenyx has an incredible reputation as a leader in the biopharma industry that solves scientific, development and commercial hurdles to accelerate innovation in rare diseases. I became a believer in the company's future while leading Genzyme's investment in its Series B financing and have followed its progress as it brought forward","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2569656737","title":"Cantor Fitzgerald Keeps Their Buy Rating on Ultragenyx Pharmaceutical (RARE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2569656737","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2569656737?lang=en_us&edition=fundamental","pubTime":"2025-09-23 03:15","pubTimestamp":1758568541,"startTime":"0","endTime":"0","summary":"In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Ultragenyx Pharmaceutical, with a price target of $105...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-ultragenyx-pharmaceutical-rare-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cantor-fitzgerald-keeps-their-buy-rating-on-ultragenyx-pharmaceutical-rare-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE"],"gpt_icon":0},{"id":"2568829453","title":"Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2568829453","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2568829453?lang=en_us&edition=fundamental","pubTime":"2025-09-20 04:30","pubTimestamp":1758313800,"startTime":"0","endTime":"0","summary":"NOVATO, Calif., Sept.  19, 2025  (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/19/3153402/20739/en/Ultragenyx-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["USJW.SI","QLD",".IXIC","BK4139","USAW.SI","NVIW.SI","QID","SQQQ","TSYW.SI","PSQ","NQmain","MNQmain","QQQ","TQQQ","RARE"],"gpt_icon":0},{"id":"2567901141","title":"Karah Parschauer, EVP and Chief Legal Officer, Reports Disposal of Common Shares of Ultragenyx Pharmaceutical Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2567901141","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567901141?lang=en_us&edition=fundamental","pubTime":"2025-09-13 04:12","pubTimestamp":1757707959,"startTime":"0","endTime":"0","summary":"Karah Parschauer, EVP and Chief Legal Officer of Ultragenyx Pharmaceutical Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ultragenyx Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 12, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250912:nNDL6Ht5Jx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RARE"],"gpt_icon":0},{"id":"2566962317","title":"Ultragenyx Pharmaceutical: Promising Phase 3 Results for DTX401 Reinforce Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2566962317","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566962317?lang=en_us&edition=fundamental","pubTime":"2025-09-11 18:36","pubTimestamp":1757586976,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on RARE stock, giving a Buy rating on September 9. Joseph Schwartz has...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/ultragenyx-pharmaceutical-promising-phase-3-results-for-dtx401-reinforce-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/ultragenyx-pharmaceutical-promising-phase-3-results-for-dtx401-reinforce-buy-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RARE"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":1,"totalSize":84,"code":"91000000","status":"200"}]}}